List of Figures
Figure 1: Global MRI Systems Market Size, By Value, 2016-2026 (USD Million)
Figure 2: Number of magnetic resonance imaging (MRI) units in selected countries as of 2019, (per million population)
Figure 3: Radiologists Per 100,000 people in Selected Countries, 2018
Figure 4: Global burden of disease by cause measured in Disability-Adjusted Life Years, in millions, in 2018
Figure 5: Global burden of musculoskeletal conditions region wise in millions, year 2020
Figure 6: Global Estimated number of Cancer incidences and prevalent cases (all ages, in millions), Year 2020
Figure 7: Global Cancer related number of deaths (all ages, in millions), Year 2020
Figure 8: Current Healthcare Expenditure (% Share of GDP), By Selected Country, 2014-2018 (In %)
Figure 9: Global Aged Population (Above 65), 2016-20 (% of total Population)
Figure 10: Global Aged Population (Above 65), By Country, 2020 (% of total Population)
Figure 11: Global MRI Systems Market- By Architecture Market Share, 2020 & 2026
Figure 12: Global MRI Systems Market- By Closed MRI Systems, By Value (USD Million), 2016-2026
Figure 13: Global MRI Systems Market- By Open MRI Systems, By Value (USD Million), 2016-2026
Figure 14: Global MRI Systems Market- By Field Strength Market Share, 2020 & 2026
Figure 15: Global MRI Systems Market- By Less than 1.5T, By Value (USD Million), 2016-2026
Figure 16: Global MRI Systems Market- By 1.5T 3T, By Value (USD Million), 2016-2026
Figure 17: Global MRI Systems Market- By More than 3T, By Value (USD Million), 2016-2026
Figure 18: Global MRI Systems Market - By Application Market Share, 2020 & 2026
Figure 19: Global MRI Systems Market- By Neurology, By Value (USD Million), 2016-2026
Figure 20: Global MRI Systems Market- By Musculoskeletal, By Value (USD Million), 2016-2026
Figure 21: Global MRI Systems Market- By Cardiology, By Value (USD Million), 2016-2026
Figure 22: Global MRI Systems Market- By Others, By Value (USD Million), 2016-2026
Figure 23: Global MRI Systems Market- By Region Market Share, 2020 & 2026
Figure 24: North America MRI Systems Market Size, By Value, 2016-2026 (USD Million)
Figure 25: North America Current health expenditure per capita (current USD), 2014-18
Figure 26: North America Population ages 65 and above (% of total Population), 2016-20
Figure 27: Burden of Neurological Conditions in the region in 2019, (in % terms per 100,000 population)
Figure 28: North America estimated number of Cancer incidences and prevalent cases (in millions), Year 2020
Figure 29: North America Cancer related number of deaths (all ages, in thousand's), Year 2020
Figure 30: North America Current health expenditure per capita (current USD), 2014-18
Figure 31: North America Population ages 65 and above (% of total Population), 2016-20
Figure 32: North America MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026
Figure 33: North America MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026
Figure 34: North America MRI Systems Market- By Application, By Value (USD Million), 2016-2026
Figure 35: Market Opportunity Chart of North America MRI Systems Market- By Country, By Value (Year-2026)
Figure 36: North America MRI Systems Market- By Country Market Share, 2020 & 2026
Figure 37: United States MRI Systems Market Size, By Value, 2016-2026 (USD Million)
Figure 38: United States Current health expenditure per capita (current USD), 2015-2019
Figure 39: United States Population aged 65 and above (% of total Population), 2016-20
Figure 40: Number of deaths (per 100,000 people) from Neurological conditions in the U.S., 2016-19
Figure 41: Cancer Prevalence in United States, 2020
Figure 42: United States MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026
Figure 43: United States MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026
Figure 44: United States MRI Systems Market- By Application, By Value (USD Million), 2016-2026
Figure 45: Canada MRI Systems Market Size, By Value, 2016-2026 (USD Million)
Figure 46: Number of deaths (per 100,000 people) from Neurological conditions in Canada, 2016-19
Figure 47: Estimated number of Cancer Prevalent cases in Canada, 2020
Figure 48: Key areas of Expenditure in Canada Medical Technology
Figure 49: Canada Current health expenditure per capita (current USD), 2014-19
Figure 50: Canada Population aged 65 and above (% of total Population), 2016-20
Figure 51: Canada MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026
Figure 52: Canada MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026
Figure 53: Canada MRI Systems Market- By Application, By Value (USD Million), 2016-2026
Figure 54: Europe MRI Systems Market Size, By Value, 2016-2026 (USD Million)
Figure 55: Europe Current health expenditure per capita (current USD), 2015-18
Figure 56: Total expenditure on health per capita in European countries (in USD PPP), 2019
Figure 57: Europe Population ages 65 and above (% of total Population), 2016-20
Figure 58: Population ages 65 and above (% of total Population) in European Countries, 2020
Figure 59: Europe estimated number of Cancer prevalence (all ages, in thousands), Year 2020
Figure 60: Europe Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 61: Europe Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 62: Europe MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026
Figure 63: Europe MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026
Figure 64: Europe MRI Systems Market- By Application, By Value (USD Million), 2016-2026
Figure 65: Market Opportunity Chart of Europe MRI Systems Market- By Country, By Value (Year-2026)
Figure 66: Europe MRI Systems Market- By Country Market Share, 2020 & 2026
Figure 67: Germany MRI Systems Market Size, By Value, 2016-2026 (USD Million)
Figure 68: Germany Healthcare Industry Scenario (2016-2019)
Figure 69: Germany, Population ages 65 and above (% total), 2016-2020
Figure 70: Germany, Estimated percentage of prevalent Cancer cases, 2020
Figure 71: Germany Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 72: Germany Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 73: Germany MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026
Figure 74: Germany MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026
Figure 75: Germany MRI Systems Market- By Application, By Value (USD Million), 2016-2026
Figure 76: France MRI Systems Market Size, By Value, 2016-2026 (USD Million)
Figure 77: France Current health expenditure per capita (current USD ), 2015-19
Figure 78: France, Population ages 65 and above (% of total Population), 2016-20
Figure 79: France Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 80: France Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 81: France, Estimated percentage of prevalent Cancer cases, 2020
Figure 82: France MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026
Figure 83: France MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026
Figure 84: France MRI Systems Market- By Application, By Value (USD Million), 2016-2026
Figure 85: Italy MRI Systems Market Size, By Value, 2016-2026 (USD Million)
Figure 86: Italy Current health expenditure per capita (current USD), 2015-19
Figure 87: Italy Population ages 65 and above (% of total Population), 2016-20
Figure 88: Italy Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 89: Italy Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 90: Italy, Estimated percentage of prevalent Cancer cases, 2020
Figure 91: Italy MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026
Figure 92: Italy MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026
Figure 93: Italy MRI Systems Market- By Application, By Value (USD Million), 2016-2026
Figure 94: United Kingdom MRI Systems Market Size, By Value, 2016-2026 (USD Million)
Figure 95: United Kingdom Current health expenditure per capita, PPP USD, 2015-19
Figure 96: United Kingdom Population ages 65 and above (% of total Population), 2016-20
Figure 97: United Kingdom Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 98: United Kingdom Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 99: United Kingdom, Estimated percentage of prevalent Cancer cases, 2020
Figure 100: United Kingdom MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026
Figure 101: United Kingdom MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026
Figure 102: United Kingdom MRI Systems Market- By Application, By Value (USD Million), 2016-2026
Figure 103: Asia Pacific MRI Systems Market Size, By Value, 2016-2026 (USD Million)
Figure 104: Asia Pacific, Current health expenditure per capita (current USD), 2015-18
Figure 105: Asia Pacific, Current health expenditure per capita, by countries (current USD), 2019
Figure 106: Asia Pacific, Population ages 65 and above (% of total Population), 2016-20
Figure 107: Asia Pacific Population ages 65 and above, by Countries (% of total Population), 2020
Figure 108: Number of MRI units in APAC countries as of 2019, (per million population)
Figure 109: Asia Pacific Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 110: Different Cancers prevalence in Asia Pacific (all ages, in thousands), Year 2020
Figure 111: Asia Pacific MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026
Figure 112: Asia Pacific MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026
Figure 113: Asia Pacific MRI Systems Market- By Application, By Value (USD Million), 2016-2026
Figure 114: Market Opportunity Chart of APAC MRI Systems Market- By Country, By Value (Year-2026)
Figure 115: APAC MRI Systems Market- By Country Market Share, 2020 & 2026
Figure 116: China MRI Systems Market Size, By Value, 2016-2026 (USD Million)
Figure 117: China Current health expenditure per capita (current USD), 2014-18
Figure 118: China Population ages 65 and above (% of total Population), 2016-20
Figure 119: China Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 120: China Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 121: Estimated number of Cancer prevalent cases in China (all ages, in thousands), Year 2020
Figure 122: China MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026
Figure 123: China MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026
Figure 124: China MRI Systems Market- By Application, By Value (USD Million), 2016-2026
Figure 125: Japan MRI Systems Market Size, By Value, 2016-2026 (USD Million)
Figure 126: Japan Healthcare Expenditure Outlook (%)
Figure 127: Japan Population ages 65 and above (% of total Population), 2016-20
Figure 128: Japan Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 129: Japan Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 130: Estimated number of Cancer prevalent cases in Japan (all ages, in thousands), Year 2020
Figure 131: Japan MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026
Figure 132: Japan MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026
Figure 133: Japan MRI Systems Market- By Application, By Value (USD Million), 2016-2026
Figure 134: India MRI Systems Market Size, By Value, 2016-2026 (USD Million)
Figure 135: Estimated value of public health spending in India (from 2017-20, in billions USD)
Figure 136: India population ages 65 and above (% of total Population), 2016-20
Figure 137: India Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 138: India Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 139: Estimated number of Cancer prevalent cases in India (all ages, in thousands), Year 2020
Figure 140: India MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026
Figure 141: India MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026
Figure 142: India MRI Systems Market- By Application, By Value (USD Million), 2016-2026
Figure 143: Australia MRI Systems Market Size, By Value, 2016-2026 (USD Million)
Figure 144: Australia Current health expenditure per capita (current USD), 2014-19
Figure 145: Australia Population ages 65 and above (% of total Population), 2016-20
Figure 146: Australia Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 147: Australia Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 148: Estimated number of Cancer prevalent cases in Australia (all ages, in thousands), Year 2020
Figure 149: Australia MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026
Figure 150: Australia MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026
Figure 151: Australia MRI Systems Market- By Application, By Value (USD Million), 2016-2026
Figure 152: Market Attractiveness Chart of Global MRI Systems Market- By Architecture (Year-2026)
Figure 153: Market Attractiveness Chart of Global MRI Systems Market- By Field Strength (Year-2026)
Figure 154: Market Attractiveness Chart of Global MRI Systems Market - By Application, By Value (Year 2026)
Figure 155: Market Attractiveness Chart of Global MRI Systems Market- By Region (Year-2026)
Figure 156: Global MRI Systems company market share (%), 2020
Figure 157: Siemens Healthineers Annual Sales Revenue, 2017-2021 (USD Million)
Figure 158: Siemens Healthineers Net Income, 2017-2021 (USD Million)
Figure 159: Siemens Healthineers Sales Revenue, By Business Segment (%), FY2021
Figure 160: Siemens Healthineers Sales Revenue, By Geographical Segment (%), FY2021
Figure 161: General Electric Annual Sales Revenue, 2016-2020 (USD Million)
Figure 162: General Electric Net Income, 2016-2020 (USD Million)
Figure 163: General Electric Sales Revenue, By Business Segment (%), FY2020
Figure 164: General Electric Sales Revenue, By Geographical Segment (%), FY2020
Figure 165: Philips Annual Sales Revenue, 2016-2020 (USD Million)
Figure 166: Philips Net Income, 2016-2020 (USD Million)
Figure 167: Philips Sales Revenue, By Business Segment (%), FY2020
Figure 168: Philips Sales Revenue, By Geographical Segment (%), FY2020
Figure 169: Canon Medical Systems Annual Sales Revenue, 2016-2020 (USD Million)
Figure 160: Canon Medical Systems Net Income, 2016-2020 (USD Million)
Figure 171: Canon Medical Systems Corporation Sales Revenue, By Business Segment (%), FY2020
Figure 172: Canon Medical Systems Corporation Sales Revenue, By Geographical Segment (%), FY2020
Figure 173: Hitachi Ltd. Annual Sales Revenue, 2016-2020 (USD Million)
Figure 174: Hitachi Ltd. Net Income, 2016-2020 (USD Million)
Figure 175: Hitachi Ltd. Sales Revenue, By Business Segment (%), FY2020
Figure 176: Hitachi Ltd. Sales Revenue, By Geographical Segment (%), FY2020
Figure 177: Fonar Corporation Annual Sales Revenue, 2017-2021 (USD Million)
Figure 178: Fonar Corporation Gross Profit, 2017-2021 (USD Million)
Figure 179: Fonar Corporation Sales Revenue, By Business Segment (%), FY2021
Figure 180: Fonar Corporation Sales Revenue, By Geographical Segment (%), FY2021